Bicycle Therapeutics Plc (BCYC)
4.34
-0.03
(-0.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.42
+0.08
(+1.84%)
After-Hours: 20:00
Bicycle Therapeutics Debt to Equity Ratio : 0.0298 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0298 |
| March 31, 2026 | 0.0288 |
| December 31, 2025 | 0.0287 |
| September 30, 2025 | 0.0105 |
| June 30, 2025 | 0.0119 |
| March 31, 2025 | 0.0123 |
| December 31, 2024 | 0.012 |
| September 30, 2024 | 0.0133 |
| June 30, 2024 | 0.0489 |
| March 31, 2024 | 0.1231 |
| December 31, 2023 | 0.1212 |
| September 30, 2023 | 0.1098 |
| June 30, 2023 | 0.2139 |
| March 31, 2023 | 0.2034 |
| December 31, 2022 | 0.1637 |
| September 30, 2022 | 0.1521 |
| June 30, 2022 | 0.1463 |
| March 31, 2022 | 0.1426 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.128 |
| September 30, 2021 | 0.1936 |
| June 30, 2021 | 0.2337 |
| March 31, 2021 | 0.2339 |
| December 31, 2020 | 0.1653 |
| September 30, 2020 | 0.1438 |
| June 30, 2020 | 0.0212 |
| March 31, 2020 | 0.0207 |
| December 31, 2019 | 0.0203 |
| September 30, 2019 | 0.0212 |
| June 30, 2019 | 0.0213 |
| March 31, 2019 | 0.0496 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Autolus Therapeutics Plc | 4.915 |
| Akari Therapeutics Plc | 0.0373 |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | 0.0784 |
| Cellectis SA | 2.539 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 606.58M |
| Total Liabilities (Quarterly) | 96.32M |
| Shareholders Equity (Quarterly) | 510.26M |
| Current Ratio | 12.08 |
| Net Debt Paydown Yield | -0.57% |